Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Does a common EB gel raise or lower cancer risk? new 5-year study aims to find out.

NCT ID NCT06423573

First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 34 times

Summary

This study follows about 580 people with a rare skin condition called epidermolysis bullosa (EB) for up to 5 years. Researchers want to see if using Filsuvez gel, which helps heal skin blisters, changes the chance of developing skin cancer. Participants receive standard care, and the study simply observes what happens over time.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EPIDERMOLYSIS BULLOSA, DYSTROPHIC are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • CHU de Toulouse, Hôpital Larrey

    RECRUITING

    Toulouse, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Guy's and St Thomas' NHS Foundation Trust

    RECRUITING

    London, United Kingdom

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Hospital Clinic, Barcelona

    RECRUITING

    Barcelona, Spain

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Hospital San Juan de Dios (Barcelona)

    RECRUITING

    Barcelona, Spain

    Contact Email: •••••@•••••

    Contact

  • Hospital of Skin and Venereal Diseases of Thessaloniki

    RECRUITING

    Thessaloniki, Greece

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.